{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"MONEY BALL Episode 2 - Robert Boyce, Plakous Therapeutics","html":"","width":"100%","height":180,"duration":1679,"description":"This episode is part of a limited series called Money Ball in conjunction with the BLPN Club . BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.\nIn this episode, Rob Boyce, CEO of Plakous Therapeutics, discusses the company's mission to develop regenerative medicine solutions for necrotizing enterocolitis (NEC), a devastating disease affecting premature infants. He shares insights into the challenges of developing treatments for this vulnerable population, the importance of funding, and the role of networking in the biotech industry. Rob also highlights a case study of a patient named Laurel, illustrating the potential impact of their product on improving outcomes for babies at risk of NEC.\nChapters:\n00:00 Introduction to Plakous Therapeutics\n01:08 Understanding Necrotizing Enterocolitis (NEC)\n04:23 The Genesis of Plakous Therapeutics\n06:24 Innovative Approach to Treatment\n09:27 Real-Life Impact: Case Study of Laurel\n13:32 Navigating the Funding Landscape\n16:06 Refining the Pitch Process\n22:05 Challenges in the Current Investment Climate\n25:11 Current Stage and Future Plans\nGuest Information:Guest's Name: Robert BoyceGuest's Title/Position:  Chief Executive OfficerGuest's Linkedin:https://www.linkedin.com/in/robertwboyce/Company / Affiliation: Plakous Therapeutics https://www.plakoustherapeutics.com/Guest's Bio:  Rob Boyce is the CEO of Plakous Therapeutics, Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. Prior to Plakous Rob was at Imago Systems, Inc., a software as a service medical diagnostic company seeking to redefine the medical imaging. He started his business career at Johnson & Johnson, marketing the Tylenol Brand. While at J&J he led worldwide Sales and Marketing for Independence Technology, a Johnson & Johnson company specializing in...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}